Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Ancora Advisors LLC

Ancora Advisors LLC lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 4.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,226 shares of the medical research company’s stock after acquiring an additional 275 shares during the quarter. Ancora Advisors LLC’s holdings in Agilent Technologies were worth $1,051,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Raymond James & Associates lifted its holdings in Agilent Technologies by 38.1% in the 4th quarter. Raymond James & Associates now owns 104,974 shares of the medical research company’s stock worth $14,595,000 after buying an additional 28,965 shares in the last quarter. Ritholtz Wealth Management acquired a new position in Agilent Technologies in the 4th quarter worth $255,000. Global Retirement Partners LLC lifted its holdings in Agilent Technologies by 31.7% in the 4th quarter. Global Retirement Partners LLC now owns 1,905 shares of the medical research company’s stock worth $249,000 after buying an additional 459 shares in the last quarter. Fifth Third Bancorp lifted its holdings in Agilent Technologies by 47.4% in the 4th quarter. Fifth Third Bancorp now owns 29,861 shares of the medical research company’s stock worth $4,152,000 after buying an additional 9,609 shares in the last quarter. Finally, Oak Thistle LLC lifted its holdings in Agilent Technologies by 8.2% in the 4th quarter. Oak Thistle LLC now owns 4,121 shares of the medical research company’s stock worth $573,000 after buying an additional 314 shares in the last quarter.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $140.00, for a total value of $274,120.00. Following the transaction, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at approximately $3,650,640. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $140.00, for a total value of $274,120.00. Following the transaction, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at approximately $3,650,640. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the transaction, the senior vice president now directly owns 49,486 shares in the company, valued at $6,595,494.08. The disclosure for this sale can be found here. Over the last three months, insiders have sold 18,916 shares of company stock valued at $2,527,860.

Agilent Technologies Stock Up 1.4 %

A traded up $1.91 during trading hours on Wednesday, hitting $141.40. 2,318,449 shares of the company’s stock were exchanged, compared to its average volume of 1,773,457. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $155.35. The stock’s 50-day moving average is $133.93 and its two-hundred day moving average is $137.75. The stock has a market cap of $41.25 billion, a price-to-earnings ratio of 32.98, a PEG ratio of 4.67 and a beta of 1.05. The company has a quick ratio of 1.64, a current ratio of 2.15 and a debt-to-equity ratio of 0.34.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 29th. The medical research company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.03. The firm had revenue of $1.57 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The company’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.27 earnings per share. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd were given a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend was Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio is 22.22%.

Wall Street Analyst Weigh In

A has been the subject of a number of recent research reports. Bank of America boosted their price objective on shares of Agilent Technologies from $134.00 to $140.00 and gave the company a “neutral” rating in a research report on Tuesday, June 25th. UBS Group cut their target price on shares of Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating for the company in a research note on Thursday, May 30th. Wolfe Research lowered shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. Barclays dropped their price objective on shares of Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating on the stock in a research note on Friday, May 31st. Finally, TD Cowen reiterated a “buy” rating and issued a $153.00 price objective on shares of Agilent Technologies in a research note on Monday. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $138.06.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.